Metrics
14 Record Views
Journal article
The Application of Machine Learning in Warfarin Dose Precision for Diabetic Patients Treated with Statins: A Comparative Study
Cardiovascular drugs and therapy, Vol.online ahead of print
05/31/2025
PMID: 40448807
Web of Science ID: WOS:001499202800001
Abstract
Purpose: To evaluate the impact of statin therapy on warfarin dose requirements in diabetic patients and to assess the performance of various machine learning algorithms in predicting optimal warfarin dosing.
Methods: The datasets available for total participants of 628 (216 diabetics and 412 non-diabetic patients) were analyzed. We categorized the patients according to height, weight, gender, race, and age, plasma international normalized ratio (INR) on reported therapeutic dose of warfarin, target INR, warfarin dose, statin therapy, and indications for warfarin. Various models were tested on data of patients from the International Warfarin Pharmacogenetics Consortium (IWPC). Data preprocessing involves structuring and handling missing values. Six predictive models, including least absolute shrinkage and selection operator (LASSO), k-nearest neighbors (KNN), support vector regression (SVR), linear regression (LR), decision tree, and random forest (RF), were employed in predicting optimal warfarin dosage. The best dose for each patient will be predicted using one of the six regression models.
Results: This comparative study showed that the mean (and the standard deviation) of warfarin dose for diabetic and non-diabetic patients were 38.73 (15.37) and 34.50 (18.27) mg per week, respectively. Furthermore, the impact of various statin they use is considered and patient undergoing atorvastatin and rosuvastatin therapy against the necessity of high dose warfarin if the diabetic patients use lovastatin and fluvastatin.
Conclusion: Diabetic patients under statin therapy, considering the specific statin used, require different warfarin dose. Through the application of advanced machine learning, models as dosing predictors may attenuate the adverse effects of warfarin.
Related links
Details
- Title
- The Application of Machine Learning in Warfarin Dose Precision for Diabetic Patients Treated with Statins
- Publication Details
- Cardiovascular drugs and therapy, Vol.online ahead of print
- Resource Type
- Journal article
- Publisher
- Springer Nature
- Number of pages
- 14
- Copyright
- © 2025, The Author(s), under exclusive licence to Springer Science Business Media, LLC, part of Springer Nature
- Identifiers
- WOS:001499202800001; 99381494458106600
- Academic Unit
- Cybersecurity and Information Technology; Hal Marcus College of Science and Engineering
- Language
- English